Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07724886
NA

A Randomised Trial Investigating the Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This is a prospective, multi-centre randomised trial comparing between cTURBT plus 1-year BCG therapy, and ERBT plus 1-year BCG therapy, in patients with intermediate-risk or high-risk NMIBC.

Official title: A Randomised Trial Investigating the Role of Transurethral En Bloc Resection of Bladder Tumour Plus Intravesical Bacillus Calmette-Guerin Therapy, in Patients With Intermediate-Risk or High-Risk Non-Muscle-Invasive Bladder Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

732

Start Date

2026-07-01

Completion Date

2030-03-31

Last Updated

2026-07-24

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Conventional Transurethral Resection of Bladder Tumour

Conventional TURBT is performed by resecting the bladder tumour in a piecemeal manner with a top-down approach. The bladder tumour specimen is fragmented during the procedure and whether a complete resection has been achieved is determined by the operating surgeon's judgment intra-operatively.

PROCEDURE

Transurethral En Bloc Resection of Bladder Tumour

This surgical technique resects the bladder tumour underneath the submucosal plane, and the bladder tumour can be removed in one piece.

Locations (2)

Prince of Wales Hospital

Hong Kong, Hong Kong

North District Hospital

Sheung Shui, Hong Kong